Among its partners are a diverse set of institutions, including research institutes, international organisations, private foundations, universities and other academic entities, bilateral and multilateral initiatives, NGOs and private sector groups.
The Ministry of Foreign and European Affairs funds many of the Institut Pasteur’s international programmes and programmes that are carried out by members of the Institut Pasteur International Network. In particular, the Ministry of Foreign and European Affairs finances FSP programmes such as the FSP Meningitis project, and has previously funded an FSP project on antibiotic resistance. The Ministry of Foreign and European Affairs also funds researcher exchange visits via the Hubert Curien Partnership and technical assistant positions within the International Network.
The "Support, Training and Capacity Improvement" programme aims to improve monitoring networks for influenza viruses (particularly the avian influenza virus) in Africa and South-East Asia and to carry out epidemiological studies. To meet these objectives, this programme provides appropriate training to ensure that support is available for investigations in the event of an epidemic.
The Ministry of Higher Education and Research provides different types of funding for research at the Institut Pasteur. In 2008, its contribution totalled €47.3 million.
The National Institutes of Health (NIH) is an Operating Division within the Department of Health and Human Services (HHS). The NIH is the steward of biomedical and behavioral research for the Nation. Its mission is science in pursuit of fundamental knowledge about the nature and behavior of living systems and the application of that knowledge to extend healthy life and reduce the burdens of illness and disability.
The Ministry of Health and Sports provides funding for many of the major programmes in the Institut Pasteur International Network, one of which is an influenza programme in Africa. In addition, the Ministry of Health and Sport has financed the building of a new training facility at the National Institute of Hygiene and Epidemiology (NIHE) in Hanoi. The Institut Pasteur in Paris houses half of France’s National Reference Centres (CNR): these are partly funded by the French Institute for Public Health (InVS), which operates under the aegis of the Ministry of Health and Sport.
The CDC is one of the major operating components of the Department of Health and Human Services (HHS). The CDC collaborates to create the expertise, information, and tools that people and communities need to protect their health through health promotion, prevention of disease, injury and disability, and preparedness for new health threats. CDC's Official Mission Statements/Organizational Charts
Academic or Research Establishments
In 2008 the Institut Pasteur signed a collaboration agreement with the Harvard School of Public Health (Harvard University) to formalise their shared work in the field of research into infectious diseases. This collaboration involves a researcher exchange programme between the two campuses so that knowledge and scientific progress can be shared.
Since 1975, the Pasteur-Weizmann Council has been instrumental in promoting and supporting scientific collaborations between the Institut Pasteur and the Weizmann Institute, a world leader in basic and applied research. This collaboration involves International Symposia, exchanges of scientists, joint research projects and fellowships for students and post-doctoral visitors.
In 1985, the Institut Pasteur signed a partnership agreement with the Riken Institute, the premier research institute in Japan, and both institutes are still engaged in collaborative work. In Japan, the Institut Pasteur is also a partner of the National Institute of Infectious Diseases.
The Franco-Chinese Pole in life sciences and genomics in Shanghai was established in 2002 under the Ministry of Research and Technology of China in partnership with INSERM, CNRS and the Institut Pasteur. It is located in Rui Jin Hospital affiliated to Shanghai Jiao Tong University.
Within Pole, Chinese and French researcher (CNRS, INSERM and Institut Pasteur) join forces to promote biomedical research in the field of genomics and cancer biology.
The Total Foundation is a long-term partner of the Institut Pasteur and its international network against the health inequalities. Since 2005 the support of the Foundation has contributed to the development of a number of innovative research projects in Paris as well as programmes combining research and public health actions in countries where both the TTotal Group and the Institut Pasteur operates. The support from the Total Foundation aims at improving the prevention, diagnosis and treatment of infectious disease in particular in children. In addition, it contributes to the training of healthcare professionals and to the reinforcement of local infrastructures.
Aware of the major impact of infectious encephalitis in terms of mortality and neurological consequences on the population in South-East Asia, the Fondation Mérieux, private foundation recognized of public utility, supports the "infectious Encephalitis in South East Asia or SEAe "along with several partners.
Institut Pasteur researchers receive financial support from the Gates Foundation via calls for proposals for its “Grand Challenges Explorations” (GCE) initiative. The aim of this initiative is to support highly innovative research projects that can make a contribution to solving health problems in developing countries. The "Vaccine Discovery by Mapping Quasispecies Sequence Space" project by Marco Vignuzzi, from the five-year group on viral populations and pathogenesis, is one of the projects selected to receive funding as it responds to one of the foundation’s challenges (“Create new ways to protect against infectious diseases"). Out of over 3,000 proposals submitted, this project is the only one to have been selected from France and is one of only 10 to have been chosen from Europe.
The Institut Pasteur signed an agreement with the Wellcome Trust on 14 November 2008, sealing a partnership to promote immunology research and research into infectious diseases, tropical diseases and neglected diseases in humans and animals. The Institut Pasteur and the Wellcome Trust have agreed on specific areas for collaboration and will have an annual meeting to review how the collaboration has progressed.
The Amsud- Pasteur program was initiated in 2001 between the Director General of the Institut Pasteur and the Minister of Foreign Affairs of Uruguay, Presidency of MERCOSUR. It allowed the establishment of a cooperative network with 72 universities, centers or research groups in five member countries of the Southern Cone. The Amsud-Pasteur program was completed in December 2013. The Amsud-Pasteur Website (spanish).
DNDi (Drugs for Neglected Diseases Initiative) a pour but de soutenir la recherche et le développement de médicaments et vaccins contre les maladies négligées (trypanosomiase, leishmaniose, etc). Une fondation de droit suisse créée en 2003, les six membres fondateurs se sont réunis pour la première fois à l’Institut Pasteur les 13 et 14 mars 2003. Ces six partenaires sont le Conseil indien pour la Recherche médicale, la Fondation Oswaldo Cruz (Brésil), l’Institut Pasteur (France), l’Institut de Recherche médicale du Kenya, Médecins Sans Frontières et le Ministère de la Santé de Malaisie. DNDi travaillera en étroite collaboration avec le Programme des Nations Unies pour le Développement (PNUD), la Banque mondiale et le Programme spécial de Recherche et de Formation sur les Maladies Tropicales de l’Organisation Mondiale de la Santé (OMS/TRD).
L’Institut Pasteur participe au Conseil d’Administration de Bioforce depuis sa création en 1983. Dans le cadre de leur collaboration, les stagiaires de Bioforce sont accueillis au sein du Réseau International des Instituts Pasteur et les chercheurs de ce dernier bénéficient des formations Bioforce.
Founded in 1972, the Agence de Médecine Préventive (AMP) is a French nonprofit organization dedicated to promoting preventive medicine and public health in sub-Saharan Africa and low- and middle-income countries worldwide. In collaboration with diverse public- and private-sector partners, AMP supports countries to develop evidence-based, sustainable immunization policies and to strengthen their public health and immunization systems.